The EVICEL® Neurosurgery Phase III Study
Public ClinicalTrials.gov record NCT02457546. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Single-Blinded, Randomized, Controlled Study to Evaluate the Safety and Effectiveness of EVICEL® Fibrin Sealant (Human) Compared to a Hydrogel Sealant as an Adjunct to Sutured Dural Repair
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of this study is to evaluate the safety and efficacy of EVICEL® Fibrin Sealant (Human) for use as an adjunct to sutured dural repair in cranial surgery.
Study identification
- NCT ID
- NCT02457546
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 234 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 1, 2015 (Actual)
- Primary completion
- Sep 13, 2017 (Actual)
- Completion
- Oct 12, 2017 (Actual)
- Last update posted
- Jan 10, 2019
2015 – 2017
United States locations
- U.S. sites
- 13
- U.S. states
- 11
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Investigation Site #27 | Los Angeles | California | 90033 | — |
| Clinical Investigation Site #17 | Sacramento | California | 95817 | — |
| Clinical Investigation Site #18 | Jacksonville | Florida | 32207 | — |
| Clinical Investigation Site #19 | Tampa | Florida | 33606 | — |
| Clinical Investigation Site #22 | Indianapolis | Indiana | 46202 | — |
| Clinical Investigation Site #10 | New Orleans | Louisiana | 70121 | — |
| Clinical Investigation Site #15 | Baltimore | Maryland | 21201 | — |
| Clinical Investigation Site #11 | Boston | Massachusetts | 02215 | — |
| Clinical Investigation Site #24 | Ann Arbor | Michigan | 48109 | — |
| Clinical Investigation Site #20 | New Brunswick | New Jersey | 08903 | — |
| Clinical Investigation Site #12 | New York | New York | 10065 | — |
| Clinical Investigation Site #14 | Cincinnati | Ohio | 45219 | — |
| Clinical Investigation Site #21 | Philadelphia | Pennsylvania | 19107 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 13 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02457546, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 10, 2019 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02457546 live on ClinicalTrials.gov.